Elisabetta Versino

3.1k total citations
50 papers, 2.1k citations indexed

About

Elisabetta Versino is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Epidemiology. According to data from OpenAlex, Elisabetta Versino has authored 50 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Public Health, Environmental and Occupational Health, 14 papers in Pediatrics, Perinatology and Child Health and 14 papers in Epidemiology. Recurrent topics in Elisabetta Versino's work include Pregnancy and preeclampsia studies (13 papers), Substance Abuse Treatment and Outcomes (10 papers) and Pregnancy and Medication Impact (8 papers). Elisabetta Versino is often cited by papers focused on Pregnancy and preeclampsia studies (13 papers), Substance Abuse Treatment and Outcomes (10 papers) and Pregnancy and Medication Impact (8 papers). Elisabetta Versino collaborates with scholars based in Italy, France and United Kingdom. Elisabetta Versino's co-authors include Fabrizio Faggiano, Patrizia Lemma, Federica Vigna‐Taglianti, Alessio Zambon, Alberto Borraccino, Luca Durelli, Pierangelo Barbero, Mauro Bergui, E. Verdun and Angelo Ghezzi and has published in prestigious journals such as The Lancet, Cochrane Database of Systematic Reviews and Kidney International.

In The Last Decade

Elisabetta Versino

46 papers receiving 2.1k citations

Peers

Countries citing papers authored by Elisabetta Versino

Since Specialization

Citations

This map shows the geographic impact of Elisabetta Versino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabetta Versino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabetta Versino more than expected).

Fields of papers citing papers by Elisabetta Versino

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabetta Versino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabetta Versino. The network helps show where Elisabetta Versino may publish in the future.

Co-authorship network of co-authors of Elisabetta Versino

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabetta Versino. A scholar is included among the top collaborators of Elisabetta Versino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabetta Versino. Elisabetta Versino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Tobacco attributable morbidity and hospital costs in Piedmont: forecast for the years 2003-2014 2024 ·Italian Journal of Public Health ·Elisabetta Versino, Maria Michela Gianino, (unknown)	0
2	Analysis of CTG patterns in cases with metabolic acidosis at birth with and without neonatal neurological alterations 2024 ·The Journal of Maternal-Fetal & Neonatal Medicine ·Rossella Attini, (unknown), Elisabetta Versino, (unknown), Emmanuele Mastretta, Silvia Parisi, (unknown), (unknown), (unknown), Ilenia Mappa, Alberto Revelli, Bianca Masturzo	0
3	Plant-based diets for CKD patients: fascinating, trendy, but feasible? A green nephrology perspective 2022 ·Clinical Kidney Journal ·Massimo Torreggiani, Antioco Fois, (unknown), Rossella Attini, (unknown), (unknown), Bianca Masturzo, Gianfranca Cabiddu, Elisabetta Versino, Giorgina Barbara Piccoli	14
4	The Hypertensive Disorders of Pregnancy: A Focus on Definitions for Clinical Nephrologists 2022 ·Journal of Clinical Medicine ·(unknown), Rossella Siligato, Massimo Torreggiani, Rossella Attini, Bianca Masturzo, (unknown), (unknown), Gianfranca Cabiddu, Domenico Santoro, Elisabetta Versino, Giorgina Barbara Piccoli	7
5	History of Preeclampsia in Patients Undergoing a Kidney Biopsy: A Biphasic, Multiple-Hit Pathogenic Hypothesis 2021 ·Kidney International Reports ·Gianfranca Cabiddu, (unknown), (unknown), Nicola Lepori, Antoine Chatrenet, Massimo Torreggiani, Rossella Attini, Bianca Masturzo, Michele Rossini, Elisabetta Versino, Gabriella Moroni, Antonello Pani, Loreto Gesualdo, Domenico Santoro, Giorgina Barbara Piccoli	8
6	Compulsory Psychiatric Admissions in an Italian Urban Setting: Are They Actually Compliant to the Need for Treatment Criteria or Arranged for Dangerous Not Clinical Condition? 2019 ·Frontiers in Psychiatry ·Francesco Oliva, Luca Ostacoli, Elisabetta Versino, (unknown), Pier Maria Furlan, Sara Carletto, Rocco Luigi Picci	10
7	A Systematic Review on Materno-Foetal Outcomes in Pregnant Women with IgA Nephropathy: A Case of “Late-Maternal” Preeclampsia? 2018 ·Journal of Clinical Medicine ·Giorgina Barbara Piccoli, (unknown), Rossella Attini, (unknown), Federica Fassio, M. Gerbino, Marilisa Biolcati, Gianfranca Cabiddu, Elisabetta Versino, Tullia Todros	21
8	Moderate Protein Restriction in Advanced CKD: A Feasible Option in An Elderly, High-Comorbidity Population. A Stepwise Multiple-Choice System Approach 2018 ·Nutrients ·Antioco Fois, Antoine Chatrenet, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Irene Capizzi, Marilisa Biolcati, Elisabetta Versino, Giorgina Barbara Piccoli	27
9	Gender Differences in Heroin Addiction and Treatment: Results from the VEdeTTE Cohort 2016 ·Substance Use & Misuse ·Federica Vigna‐Taglianti, (unknown), Federica Mathis, Elisabetta Versino, Franca Beccaria, (unknown), (unknown), (unknown), Anna Maria Bargagli, (unknown)	37
10	Vegan-vegetarian low-protein supplemented diets in pregnant CKD patients: fifteen years of experience 2016 ·BMC Nephrology ·Rossella Attini, Filomena Leone, Silvia Parisi, Federica Fassio, Irene Capizzi, Valentina Loi, Loredana Colla, Maura Rossetti, M. Gerbino, Stefania Maxia, (unknown), (unknown), Ettore Piccoli, Elisabetta Versino, Marilisa Biolcati, Paolo Avagnina, Antonello Pani, Gianfranca Cabiddu, Tullia Todros, Giorgina Barbara Piccoli	32
11	Which low-protein diet for which CKD patient? An observational, personalized approach 2014 ·Nutrition ·Giorgina Barbara Piccoli, Maria Chiara Deagostini, Federica Neve Vigotti, Martina Ferraresi, (unknown), Valentina Consiglio, (unknown), (unknown), (unknown), Emiliano Aroasio, Elisabetta Versino, F. Porpiglia	31
12	Pre-eclampsia or chronic kidney disease? The flow hypothesis 2013 ·Nephrology Dialysis Transplantation ·Giorgina Barbara Piccoli, P. Gaglioti, Rossella Attini, Silvia Parisi, (unknown), Elena Olearo, M. Oberto, Martina Ferraresi, Alessandro Rolfo, Elisabetta Versino, Marilisa Biolcati, Tullia Todros	44
13	Does substance use disorder affect clinical expression in first-hospitalization patients with schizophrenia? Analysis of a prospective cohort 2013 ·Psychiatry Research ·Rocco Luigi Picci, Elisabetta Versino, Francesco Oliva, (unknown), Luca Ostacoli, (unknown), (unknown), Pier Maria Furlan	18
14	Type 2 diabetes mellitus and chronic hepatitis C: Which is worse? Results of a long-term retrospective cohort study 2012 ·Digestive and Liver Disease ·Chiara Giordanino, (unknown), Simona Bo, Antonina Smedile, Alessia Ciancio, Elisabetta Bugianesi, Rinaldo Pellicano, Sharmila Fagoonee, Elisabetta Versino, Giuseppe Costa, (unknown), M. Sacco, Mario Rizzetto, Giorgio Maria Saracco	13
15	Neutralizing antibodies in multiple sclerosis patients treated with 375 μg interferon-β-1b 2009 ·Expert Opinion on Biological Therapy ·Luca Durelli, Pierangelo Barbero, (unknown), Bruno Ferrero, (unknown), Giulia Contessa, Stefania De Mercanti, Paolo Ripellino, (unknown), (unknown), Mauro Bergui, Elisabetta Versino, Marinella Clerico	4
16	The OPTimization of Interferon for MS Study: 375 μg interferon beta-1b in suboptimal responders 2008 ·Journal of Neurology ·Luca Durelli, Pierangelo Barbero, Mauro Bergui, Elisabetta Versino, (unknown), E. Verdun, Bruno Ferrero, Chiara Rivoiro, (unknown), (unknown), Paolo Ripellino, Denis Viglietti, Giorgio Giuliani, E. Montanari, Marinella Clerico, (unknown)	12
17	A follow-up study of heroin addicts (VEdeTTE2): study design and protocol 2007 ·Substance Abuse Treatment Prevention and Policy ·Federica Vigna‐Taglianti, Federica Mathis, Roberto Diecidue, (unknown), Antonio Iannaccone, (unknown), Piergiorgio Zuccaro, Roberta Pacifici, Elisabetta Versino, Marina Davoli, Fabrizio Faggiano	2
18	Tobacco smoke in Piedmont: attributable morbidity and impact on hospital costs 2006 ·Italian Journal of Public Health ·Elisabetta Versino, Maria Michela Gianino, (unknown)	4
19	School-based prevention for illicit drugs' use 2005 ·Cochrane Database of Systematic Reviews ·Fabrizio Faggiano, Federica Vigna‐Taglianti, Elisabetta Versino, Alessio Zambon, Alberto Borraccino, Patrizia Lemma	178
20	Recreational drug consumers: who seeks treatment? 2005 ·European Journal of Public Health ·Roberta Siliquini, (unknown), Elisabetta Versino, (unknown)	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact